Extubation Failure Prevention in High Risk Patients by High-flow Conditioned Oxygen Therapy vs. Standard Oxygen Therapy
Prevention of Post-extubation Respiratory Failure in High Risk Patients by High-flow Conditioned Oxygen Therapy Versus Standard Oxygen Therapy
Sponsor: Althaia Xarxa Assistencial Universitària de Manresa
Terminated
Slow recruitment, interim analysis
Other terminated trials from Althaia Xarxa Assistencial Universitària de Manresa
- Allergy Drug · Phase NA · May 2025
- Severe Sepsis · Phase NA · Dec 2020
- Complication of Ventilation Therapy · Mar 2018
See all terminations from Althaia Xarxa Assistencial Universitària de Manresa
Other Respiratory Failure trials with similar outcome
Listed as NCT01820507, this NA trial focuses on Respiratory Failure and remains terminated or withdrawn. Sponsored by Althaia Xarxa Assistencial Universitària de Manresa, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Althaia Xarxa Assistencial Universitària de Manresa
For direct contact, visit the study record on ClinicalTrials.gov .